Injection-site |
|
|
|
|
Tenderness |
6–23 mo |
Minor reaction when injection site is touched |
Cries or protests when injection site is touched |
Cries when injected limb is moved or movement of the injected limb is reduced |
Pain |
2–11 y |
Easily tolerated |
Sufficiently discomforting to interfere with normal behavior or activities |
Incapacitating, unable to perform usual activities |
|
≥ 12 y |
No interference with activity |
Some interference with activity |
Significant, prevents daily activity |
Erythema, swelling, induration, ecchymosis |
All |
>0 to <15 mm |
≥ 15 to ≤ 30 mm |
>30 mm |
Systemic |
|
|
|
|
Fever |
All |
≥ 37.1°C to ≤ 37.5°C |
>37.5°C to ≤ 39°C |
>39°C |
Vomiting |
6–23 mo |
1 episode/24 h |
2–5 episodes/24 h |
≥ 6 episodes/24 h |
Abnormal crying |
6–23 mo |
<1 h |
1–3 h |
>3 h |
Drowsiness |
6–23 mo |
Sleepier than usual or less interested in surroundings |
Not interested in surroundings or did not wake up for a feed/meal |
Sleeping most of the time or difficult to wake |
Loss of appetite |
6–23 mo |
Eating less than normal |
Missed 1 or 2 feeds/meals completely |
Refuses ≥ 3 feeds/meals or refuses most feeds/meals |
Irritability |
6–23 mo |
Easily consolable |
Requiring increased attention |
Inconsolable |
Headache, malaise, myalgia, shivering |
≥ 2 y |
No interference with activity |
Some interference with activity |
Significant, prevents daily activity |